Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | EviCore by Evernorth | Evenity (romosozumab-aqqg) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Epoprostenol Injection (Flolan, Veletri, generic) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Epogen, Procrit, Retacrit (epoetin alfa) Injection Non-oncology | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Entyvio Intravenous (vedolizumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Enjaymo (sutimlimab-jome) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Encelto (revakinagene taroretcel-lwey) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Enbrel (etanercept) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Elfabrio (pegunigalsidase alfa) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Elelyso (taliglucerase alfa) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Elaprase (idursulfase) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Edaravone Intravenous (Radicava, generic) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Eculizumab Products (Soliris, Bkemv, Epysqli) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Dysport (abobotulinumtoxinA) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Durysta (bimatoprost intracameral implant) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Dupixent (dupilumab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Denosumab Products (Prolia, Jubbonti, Stoboclo, Conexxence, Bildyos, Ospomyv, Bosaya, Enoby) Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Daxxify (daxibotulinumtoxinA-lanm) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Crysvita (burosumab-twza) Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cosentyx Intravenous (secukinumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Coagadex (coagulation factor X [Human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cinryze (C1 esterase inhibitor [human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Cinqair (reslizumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cerezyme (imiglucerase) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cablivi (caplacizumab-yhdp) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Cabenuva (cabotegravir and rilpivirine extended-release injectable suspension) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Briumvi (ublituximab-xiiy) Intravenous Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Botox (onabotulinumtoxinA) for Medicare Advantage | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Botox (onabotulinumtoxinA) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Berinert (C1 esterase inhibitor [human]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Beovu (brolucizumab-dbll) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Benlysta (belimumab) Intravenous Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Avlayah (tividenofusp alfa-eknm) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Avastin (bevacizumab) Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Aranesp (darbepoetin alfa) Injection Non-oncology | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Aralast NP, Glassia, Prolastin-C, and Zemaira (alpha1-proteinase inhibitor [human]) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Apretude (cabotegravir intramuscular injection) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Amvuttra (vutrisiran) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Amondys 45 (casimersen) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Aldurazyme (laronidase) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Aflibercept (Eylea, Eylea HD, Pavblu) Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Adzynma (ADAMTS13 recombinant-krhn) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Adalimumab Products (Humira , Abrilada, Amjevita , Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry, adalimumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Adakveo (crizanlizumab-tmca) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Acthar Gel (repository corticotropin injection) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Screening Colonoscopy Guidelines | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Esophagogastroduodenoscopy (EGD) Guidelines | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Esophagogastroduodenoscopy (EGD) Guidelines | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Esophagogastroduodenoscopy (EGD) Guidelines | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Esophagogastroduodenoscopy (EGD) Guidelines | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Esophagogastroduodenoscopy (EGD) Guidelines | Metadata changed |